Why choose Australian medical grade cannabis?
Choosing Australian medical cannabis means:
- Doctors can be assured that what it lists on the bottle label is exactly what is inside the bottle.
- Patient safety isn’t compromised as Australia has some of the strictest quality requirements for therapeutic goods globally thanks to the Australian Government’s commitment to ensuring patient safety.
- Products comply with the Therapeutic Goods Order No. 93 (Standard for Medicinal Cannabis) (TGO 93) ensuring all products are free from pesticides, moulds, bacteria, heavy metals and other contaminants.
- Products meet Australian GMP (Good Manufacturing Practices) which is very hard to obtain and it is important to note that imported products don’t require GMP approval.
- Stability studies have been done to confirm the expiry date which you can rely on (some imported products do not have this).
- Quality, locally manufactured medical grade cannabis is provided to Australian patients.
- Medical cannabis products don’t need to come from overseas; reducing the delivery time, transport costs and out-of-stock issues.
Australian medical cannabis companies are also supporting their locals
Along with the production and manufacturing of medical cannabis, employment opportunities rise for Australians as Australian medical cannabis companies spend a lot of time and money on clinical trials based in Australia. This research and development is used to help put forward cases for Federal and State Government bodies to help ease the access barriers for patients in Australia.
An exciting future ahead for Australia
The Australian medical cannabis industry is advancing quickly with:
- Over 130+ conditions and 46,000+ SAS B applications being approved (as of 31 May 2020)
- Online SAS application process for healthcare professionals to apply on behalf of their patients resulting in faster (within 48 hours) approvals,
- Ongoing university studies and best-in-class clinical trials underway,
- Education for patients and healthcare professionals becoming more readily available.
“The Department of Health stated recently that patient numbers have increased by more than 600% in 2019. This is similar to Canada, where more than 1% of the population are medicinal cannabis patients: Australia is on a similar trajectory.” says Rosemary Richards, Executive Manager at Medicinal Cannabis Industry Australia
How is Australian medical cannabis different from ‘homegrown’ or ‘street cannabis’?
The two main differences between ‘homegrown’ or street cannabis* and medical cannabis are:
- the level of quality control, and
- the visibility and consistency of cannabinoid content, such as THC and CBD.
As street cannabis is illegal, it is not subject to quality or testing requirements. In contrast, medical cannabis in Australia is highly regulated to ensure patient safety and consistency of product formulation.
It is also important to note that medical cannabis products, including CBD-only products, that can be purchased online are considered illegal as they do not comply with Australian regulation.
A number of safety concerns result from the lack of quality control of street cannabis. Without complete chemical analysis in a certified laboratory, the composition of street cannabis is essentially unknown. It follows that concentrations of the psychoactive element, THC (tetrahydrocannabinol), may be significantly higher than expected, increasing the risk of adverse events. Products containing unknown THC levels are also a concern of patients seeking THC-free products as they may inadvertently fail drug tests for driving or work purposes.
In addition, street cannabis may also contain microbes, pesticides or other contaminants that may adversely affect patients.
*'street cannabis' refers to any product which is not tested in a laboratory and regulated by a regulatory medical agency including ‘CBD Oil’ you can buy online.